Elanco Animal Health (ELAN)
Elanco Animal Health Statistics
Share Statistics
Elanco Animal Health has 494.61M shares outstanding. The number of shares has increased by 0.28% in one year.
| Shares Outstanding | 494.61M |
| Shares Change (YoY) | 0.28% |
| Shares Change (QoQ) | 0.01% |
| Owned by Institutions (%) | 98.95% |
| Shares Floating | 489.91M |
| Failed to Deliver (FTD) Shares | 46 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 16.64M, so 3.37% of the outstanding shares have been sold short.
| Short Interest | 16.64M |
| Short % of Shares Out | 3.37% |
| Short % of Float | 3.42% |
| Short Ratio (days to cover) | 4.05 |
Valuation Ratios
The PE ratio is 17.7 and the forward PE ratio is 13.43. Elanco Animal Health's PEG ratio is -0.14.
| PE Ratio | 17.7 |
| Forward PE | 13.43 |
| PS Ratio | 1.35 |
| Forward PS | 1 |
| PB Ratio | 0.98 |
| P/FCF Ratio | 15.18 |
| PEG Ratio | -0.14 |
Enterprise Valuation
Elanco Animal Health has an Enterprise Value (EV) of 12.76B.
| EV / Earnings | 37.74 |
| EV / Sales | 2.87 |
| EV / EBITDA | 9.21 |
| EV / EBIT | 50.83 |
| EV / FCF | 32.38 |
Financial Position
The company has a current ratio of 2.44, with a Debt / Equity ratio of 0.71.
| Current Ratio | 2.44 |
| Quick Ratio | 1.25 |
| Debt / Equity | 0.71 |
| Total Debt / Capitalization | 41.48 |
| Cash Flow / Debt | 0.13 |
| Interest Coverage | 1.07 |
Financial Efficiency
Return on equity (ROE) is 0.06% and return on capital (ROIC) is 1.67%.
| Return on Equity (ROE) | 0.06% |
| Return on Assets (ROA) | 0.03% |
| Return on Capital (ROIC) | 1.67% |
| Revenue Per Employee | $493,222.22 |
| Profits Per Employee | $37,555.56 |
| Employee Count | 9,000 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 1.61 |
Taxes
| Income Tax | 150M |
| Effective Tax Rate | 0.31 |
Stock Price Statistics
The stock price has increased by -34.82% in the last 52 weeks. The beta is 1.44, so Elanco Animal Health's price volatility has been higher than the market average.
| Beta | 1.44 |
| 52-Week Price Change | -34.82% |
| 50-Day Moving Average | 11.29 |
| 200-Day Moving Average | 13.2 |
| Relative Strength Index (RSI) | 43.93 |
| Average Volume (20 Days) | 4.54M |
Income Statement
In the last 12 months, Elanco Animal Health had revenue of 4.44B and earned 338M in profits. Earnings per share was 0.68.
| Revenue | 4.44B |
| Gross Profit | 1.91B |
| Operating Income | 251M |
| Net Income | 338M |
| EBITDA | 1.39B |
| EBIT | 251M |
| Earnings Per Share (EPS) | 0.68 |
Balance Sheet
The company has 468M in cash and 4.32B in debt, giving a net cash position of -3.85B.
| Cash & Cash Equivalents | 468M |
| Total Debt | 4.32B |
| Net Cash | -3.85B |
| Retained Earnings | -1.95B |
| Total Assets | 12.61B |
| Working Capital | 1.9B |
Cash Flow
In the last 12 months, operating cash flow was 541M and capital expenditures -147M, giving a free cash flow of 394M.
| Operating Cash Flow | 541M |
| Capital Expenditures | -147M |
| Free Cash Flow | 394M |
| FCF Per Share | 0.8 |
Margins
Gross margin is 43.01%, with operating and profit margins of 5.65% and 7.61%.
| Gross Margin | 43.01% |
| Operating Margin | 5.65% |
| Pretax Margin | 10.99% |
| Profit Margin | 7.61% |
| EBITDA Margin | 31.2% |
| EBIT Margin | 5.65% |
| FCF Margin | 8.88% |
Dividends & Yields
ELAN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 6.45% |
| FCF Yield | 7.56% |
Analyst Forecast
The average price target for ELAN is $14.5, which is 37.6% higher than the current price. The consensus rating is "Hold".
| Price Target | $14.5 |
| Price Target Difference | 37.6% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
Scores
| Altman Z-Score | 1.02 |
| Piotroski F-Score | 6 |